title: Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients.
authors.forename: Rafael E
authors.initials: RE
authors.lastname: Campo
authors.forename: Rose
authors.initials: R
authors.lastname: Lalanne
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Tanner
authors.forename: Dushyantha T
authors.initials: DT
authors.lastname: Jayaweera
authors.forename: Allan E
authors.initials: AE
authors.lastname: Rodriguez
authors.forename: Lunie
authors.initials: L
authors.lastname: Fontaine
authors.forename: Michael A
authors.initials: MA
authors.lastname: Kolber
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D010865:Pilot Projects; D011744:Pyrimidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir